Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q2 2021 · 10-Q
Revenue$75.44M$75.44M+7.9% vs Q2 2020 Net Income$8.41M$8.41M+26.2% vs Q2 2020 EPS Diluted$0.42$0.42+27.3% vs Q2 2020 Gross Profit$23,018,000+15.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$26,390,000+52.9% Free Cash Flowderived$25,342,000+48.8% Margins · derivedGross margin30.5%+1.9 pt vs Q2 2020
Operating margin13.9%+1.9 pt vs Q2 2020
Net margin11.2%+1.6 pt vs Q2 2020
ended Sep 30, 2020 · filed Nov 3, 2020 · 34 d after period end